A Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of Lisdexamfetamine Dimesylate in Adults with Moderate to Severe Binge Eating Disorder

被引:0
|
作者
Hudson, James [1 ]
McElroy, Susan [1 ]
Ferreira-Cornwell, Celeste [1 ]
Radewonuk, Jana [1 ]
Gasior, Maria [1 ]
机构
[1] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA USA
关键词
binge-eating disorder; eating disorders; randomised clinical trial; Lisdexamfetamine;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
M47
引用
收藏
页码:S135 / S136
页数:2
相关论文
共 50 条
  • [21] Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study
    Corwin, Rebecca L.
    Boan, Jarol
    Peters, Kathryn F.
    Ulbrecht, Jan S.
    BEHAVIOURAL PHARMACOLOGY, 2012, 23 (5-6): : 616 - 625
  • [22] Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
    Khajavi, Danial
    Farokhnia, Mehdi
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Abbasi, Seyed-Hesammedin
    Tabrizi, Mina
    Akhondzadeh, Shahin
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (11) : 1428 - 1433
  • [23] The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: A randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm
    Biederman, Joseph
    Fried, Ronna
    Hammerness, Paul
    Surman, Craig
    Mehler, Bruce
    Petty, Carter R.
    Faraone, Stephen V.
    Miller, Carolyn
    Bourgeois, Michelle
    Meller, Benjamin
    Godfrey, Kathryn M.
    Reimer, Bryan
    JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (04) : 484 - 491
  • [24] Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study
    Thomas Babcock
    Bryan Dirks
    Ben Adeyi
    Brian Scheckner
    BMC Pharmacology and Toxicology, 13
  • [25] Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study
    Babcock, Thomas
    Dirks, Bryan
    Adeyi, Ben
    Scheckner, Brian
    BMC PHARMACOLOGY & TOXICOLOGY, 2012, 13
  • [26] Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder
    Martin, Patrick T.
    Corcoran, Mary
    Zhang, Pinggao
    Katic, Alain
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 147 - 157
  • [27] Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder
    Patrick T. Martin
    Mary Corcoran
    Pinggao Zhang
    Alain Katic
    Clinical Drug Investigation, 2014, 34 : 147 - 157
  • [28] Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder A Randomized Clinical Trial
    Hudson, James I.
    McElroy, Susan L.
    Ferreira-Cornwell, Celeste
    Radewonuk, Jana
    Gasior, Maria
    JAMA PSYCHIATRY, 2017, 74 (09) : 903 - 910
  • [29] Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled, double-blind trial
    Hudson, JI
    McElroy, SL
    Raymond, NC
    Crow, S
    Keck, PE
    Carter, WP
    Mitchell, JE
    Strakowski, SM
    Pope, HG
    Coleman, BS
    Jonas, JM
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (12): : 1756 - 1762
  • [30] Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial
    Veien, NK
    Busch-Sorensen, M
    Stausbol-Gron, B
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) : 147 - 149